Correlation Between Vaxxinity and Upstream Bio,
Can any of the company-specific risk be diversified away by investing in both Vaxxinity and Upstream Bio, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaxxinity and Upstream Bio, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaxxinity and Upstream Bio,, you can compare the effects of market volatilities on Vaxxinity and Upstream Bio, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaxxinity with a short position of Upstream Bio,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaxxinity and Upstream Bio,.
Diversification Opportunities for Vaxxinity and Upstream Bio,
-0.47 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Vaxxinity and Upstream is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Vaxxinity and Upstream Bio, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Upstream Bio, and Vaxxinity is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaxxinity are associated (or correlated) with Upstream Bio,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Upstream Bio, has no effect on the direction of Vaxxinity i.e., Vaxxinity and Upstream Bio, go up and down completely randomly.
Pair Corralation between Vaxxinity and Upstream Bio,
Given the investment horizon of 90 days Vaxxinity is expected to generate 0.89 times more return on investment than Upstream Bio,. However, Vaxxinity is 1.13 times less risky than Upstream Bio,. It trades about 0.08 of its potential returns per unit of risk. Upstream Bio, is currently generating about 0.07 per unit of risk. If you would invest 184.00 in Vaxxinity on September 29, 2024 and sell it today you would earn a total of 88.00 from holding Vaxxinity or generate 47.83% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 40.74% |
Values | Daily Returns |
Vaxxinity vs. Upstream Bio,
Performance |
Timeline |
Vaxxinity |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Upstream Bio, |
Vaxxinity and Upstream Bio, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vaxxinity and Upstream Bio,
The main advantage of trading using opposite Vaxxinity and Upstream Bio, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaxxinity position performs unexpectedly, Upstream Bio, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Upstream Bio, will offset losses from the drop in Upstream Bio,'s long position.Vaxxinity vs. Tarsus Pharmaceuticals | Vaxxinity vs. Aldeyra | Vaxxinity vs. Travere Therapeutics | Vaxxinity vs. Eton Pharmaceuticals |
Upstream Bio, vs. The Mosaic | Upstream Bio, vs. Sun Life Financial | Upstream Bio, vs. SEI Investments | Upstream Bio, vs. Hudson Technologies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |